Well said...If the tissue results are reported to be positive it will be concrete proof that it works on humans. Phase 2 results would virtually be a given as would drug approval. We will know the tissue results in 2015.The stock will go viral.
The question is why are they doing this "unusual" study. The only thing I can think of is because they are confident it will be positive (maybe they have already done them "unofficially")...or they have a partner that wants to see the results before funding Phase 2...OR both!!! This all means minimal downside, but massive potential upside. The great news is it will be starting very soon.
I also believe they have had to have done these studies on mice. If the results were negative in mice I don't think they would do it in humans.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.